Common Contracts
2 similar Eleventh Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
ELEVENTH SUPPLEMENTAL INDENTUREEleventh Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
ELEVENTH SUPPLEMENTAL INDENTURE, dated as of September 24, 2013 (the “Eleventh Supplemental Indenture”), by and among Valeant Sp. z o.o. (“VLLC”), VP Valeant spółka z ograniczoną odpowiedzialnością sp.j. (“VP”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
ELEVENTH SUPPLEMENTAL INDENTUREEleventh Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
ELEVENTH SUPPLEMENTAL INDENTURE, dated as of September 24, 2013 (the “Eleventh Supplemental Indenture”), by and among Valeant Sp. z o.o. (“VLLC”), VP Valeant spółka z ograniczoną odpowiedzialnością sp.j. (“VP”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
